Furthermore, glucagon-like peptide-1 receptor agonists (GLP-1RAs) were significantly more effective than other diabetes medications, such as metformin, sulfonylureas, and insulin, in reducing AF/AFL events. This evidence concerns the gene INS and atrial fibrillation.